Posts by: admin

News

During the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, data from different studies assessing pembrolizumab in several types of cancer showed promising activity and safety profiles. ... Read more

October 1, 2014October 1, 2014

Pfizer And Kyowa Hakko Kirin Collaborate to Develop Immunotherapy Drug

News

Pfizer Inc. and Kyowa Hakko Kirin have announced a collaboration to further develop Pfizer’s PF-05082566, an investigational, fully humanized monoclonal antibody (mAb), together with Kyowa Hakko Kirin’s anti-CCR4 antibody mogamulizumab, ... Read more

September 29, 2014September 29, 2014

Novartis-partnered Eureka Raises Substantial Capital For Immuno-Oncology Drug Research

News

Novartis and CA-based Eureka Therapeutics have landed a $21 million investment round led by Beijing-based Yuan Capital. Eureka has been developing innovative antibody cancer therapies that are engineered to mimic ... Read more

September 26, 2014September 26, 2014

Study Adds to Cancer-Fighting Promise of Combined Immunotherapy-Radiation Treatment

News

A recent study conducted by Johns Hopkins Kimmel Cancer Center researchers and presented at the 2014 annual meeting of the American Society of Radiation Oncology (ASTRO) in San Francisco by ... Read more

September 22, 2014September 22, 2014

ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T Cell Imaging

News

ImaginAb, Inc., a biotechnology company developing powerful antibody technology for in vivo imaging, has announced it has entered into an exclusive technology development partnership with Novotectid GmbH, for the production ... Read more

September 19, 2014September 19, 2014

Boehringer Ingelheim and CureVac Announce Collaboration to Develop Lung Cancer mRNA vaccine

News

Boehringer Ingelheim together with CureVac, leaders in messenger ribonucleic acid-based drug development, have announced an exclusive global license and development collaboration. Boehringer Ingelheim will develop and commercialize CureVac’s CV9202, an investigational mRNA ... Read more

September 18, 2014September 18, 2014

“Promising Innovative Medicine” Designation Awarded To DCVax-L For Glioma Treatment

News

An experimental immunotherapy developed by Northwest Biotherapeutics Inc, has been designated as “promising innovative medicine” (PIM) by the UK Medicines and Healthcare Products Regulatory Agency (MHRA), the initial step in ... Read more

September 16, 2014September 16, 2014

CaPtivate Pharmaceuticals Enters Licensing Agreement With Immunotope

News

CaPtivate Pharmaceuticals LLC, a Pennsylvania-based biotechnology company, announced it has entered into a License Agreement with Immunotope Inc., another Pennsylvania-based biotechnology company developing immunotherapy products for the treatment and prevention of viral ... Read more

September 15, 2014September 15, 2014

Monoclonal Antibodies for Gastric and Esophageal Cancers to Double by 2019

News

Reportstack, a provider of market research reports, has announced its pharma industry report on Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019, entitled “Crowded Late-Stage Pipelines and Favorable Market Conditions ... Read more

September 12, 2014September 12, 2014

NanoString Announces Novel Gene Expression Panel for Immuno-Oncology Research

News

NanoString Technologies, Inc., a company providing tools for translational research and molecular diagnostic products, has announced the introduction of a new highly multiplexed gene expression panel for the nCounter® Analysis System, ... Read more